Sales and Marketing

Showing 15 posts of 11524 posts found.

original

Bristol-Myers Squibb’s $2.3 billion gamble to boost cancer pipeline

August 4, 2017 Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, IFM Therapeutics, biotech, drugs, pharma, pharmaceutical

Bristol-Myers Squibb has agreed a deal to acquire IFM Therapeutics for a potential $2.3 billion. The latter is a biotech …
celgene_1_02

NICE greenlights Celgene pancreatic cancer drug as first-line combination treatment

August 4, 2017 Medical Communications, Sales and Marketing Cancer, Celgene, NICE, Pancreatic cancer, drugs, healthcare, life sciences, medicine, pharma, pharmaceuticals

Celgene is celebrating following NICE’s announcement that it had decided to recommend the use of nab-Paclitaxel, when used in combination …
janssen_latest_logo_on_sign

FDA turns down Janssen’s sirukumab for rheumatoid arthritis

August 3, 2017 Sales and Marketing FDA, Janssen, drugs, life sciences, medicine, pharma, pharmaceuticals, rheumatoid arthritis, sirukumab

Janssen has announced that it has suffered a knockback to its plans to commercialise sirukumab in the US in the …
astrazeneca_logo_building

AstraZeneca’s Priority Review good news provides reprieve

August 2, 2017 Sales and Marketing AstraZeneca, FDA, biotech, drugs, pharma, pharmaceutical

If there was a company that needed a series of good news stories this week, it was AstraZeneca. The blow …

Bicycle Therapeutics reveals new CFO

August 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bicycle Therapeutics, biotech, drugs, pharma, pharmaceutical

Bicycle Theapeutics, a biotech that is developing its bicyclic peptide product platform, has announced the appointed of Lee Kalowski as …
celgene_1_02

FDA approves Celgene and Agios’ acute myeloid leukaemia drug

August 2, 2017 Research and Development, Sales and Marketing Celgene, FDA, Idhifa, acute myeloid leukaemia, agios, biotech, drugs, life sciences, medicines, pharma, pharmaceuticals

The FDA has given its approval for the commercialisation of Celgene and Agios Pharmaceutical’s Idhifa for the treatment of relapsed …
daiichi_sankyo_1_0

Daiichi settles undisclosed drug side-effects case for $300 million

August 2, 2017 Research and Development, Sales and Marketing Benicar, Daiichi Sankyo, biotech, drugs, pharma, pharmaceutical

Daiichi Sankyo has settled a case alleging that it did not fully disclose adverse side-effects of its drug, Benicar, with …

Pfizer’s major drug doubles sales but overall revenue falls

August 1, 2017 Research and Development, Sales and Marketing Bavencio, Pfizer, biotech, drugs, pharma, pharmaceutical, viagra

Pfizer revealed in its briefing on its second quarter financials that Ibrance, its breast cancer treatment, had grown in sales …
anabella_villalobos

Biogen steal away Pfizer VP to boost R&D plans

August 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer has had a tough time keeping hold of its Vice President’s involved in R&D of late, losing high-profile researcher, …

New Lab-Grade Undercounter Refrigerators Use Redundant Cooling Technology to Maintain Optimal Storage Conditions

August 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical and laboratory personnel with the need to store vaccines, pharmaceuticals and other molecular or biological samples safely can benefit …
digital_tech

Learning to trust the patient’s voice

July 31, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, healthcare, patient centricity, patients, pharma, pharmaceutical

Through digital media and technology, the patient’s voice is only growing in strength and it is of growing importance that …
blood_test

HIV-screening by GPs could reduce incidence and cost

July 31, 2017 Sales and Marketing GP, HIV, NHS, biotech, drugs, pharma, pharmaceutical

Researchers have found that offering first-time patients a HIV test in an area of high-prevalence could help reduce levels of …
astrazeneca_building_white

AZ’s Imfinzi scores FDA breakthrough therapy designation in wake of major trial failure

July 31, 2017 Sales and Marketing AstraZeneca, Imfinzi, drugs, healthcare, mystic, phaarmaceutical, pharma

Still reeling from the public reaction to the flop of its key Mystic trial, where its injectable immunotherapy drug Imfinzi …
The Gateway to Local Adoption Series

Latest content